AI assistant
Sending…
Salarius Pharmaceuticals, Inc. — Director's Dealing 2020
Feb 13, 2020
35494_dirs_2020-02-12_c351bbc4-b1e1-4263-bac5-23300dfbe195.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Salarius Pharmaceuticals, Inc. (SLRX)
CIK: 0001615219
Period of Report: 2020-02-11
Reporting Person: HANISH ARNOLD C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-11 | Common Stock | P | 4350 | $1.15 | Acquired | 7350 | Direct |
More from Salarius Pharmaceuticals, Inc.
Proxy Solicitation & Information Statement
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 4
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Jan 9
Regulatory Filings
2026
Jan 8